Helex
Helex is a therapeutics company developing a new class of targeted medicines for genetic kidney diseases using its proprietary LNP drug delivery and AI-based drug design platforms. The company aims to create disease-modifying therapies for chronic and rare kidney disorders, addressing significant unmet medical needs.
Leadership & Board
- Current Number of Employees
- 37
- Current LinkedIn Followers
- 4,202
Latest Estimated Valuation
- Estimated Valuation
- ―
- Total Amount Raised
- $4M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $4M
- Latest Funding Round
- Seed Round
- Post-Money Valuation
- ―
Employee Trend
Helex had 37 employees as of October 12, 2026. The number of employees increased by 0 (0.00%) week-over-week.
37Latest Employee Count
0(0.00%)Week-Over-Week Change
Social Trend
Helex had 4,202 followers as of October 12, 2026. The number of followers increased by 3 (0.07%) week-over-week.
4,202Latest Followers Count
3(0.07%)Week-Over-Week Change
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Oct 30, 2025 | Seed Round | $3.50M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| SOSV | Seed Round |
| pi Ventures | Seed Round |
| Bluehill Capital | Seed Round |
Similar Companies
A snapshot of private companies similar to Helex, helping you discover and navigate related company profiles.
Related News and Analysis
